Promega Leadership

Dr. Linton serves as the lead director of our board of directors. He was appointed lead director in March 2004 by the independent members of the board of directors. As lead director, Dr. Linton performs the usual responsibilities of a lead director including acting as a liaison between management and the board of directors. Since 1978, Dr. Linton has served as the Chairman, President and Chief Executive Officer of Promega Corporation, Madison, Wisconsin, a privately held life science supply company founded by Dr. Linton. Dr. Linton received a B.S. degree from University of California, Berkeley in 1970 and an honorary Ph.D. from Hannam University (Korea) in 2004. Dr. Linton has been a director of the Wisconsin Technology Council since 2001 and also serves as a director of ALDA (Analytical, Life Science & Diagnostics Association), an industry association formerly known as Analytical & Life Sciences Systems Association, or ALSSA, and Heffter Research Institute, a non-profit medical research organization, and is President of the BioPharmaceutical Technology Center Institute. Dr. Linton brings to the board extensive executive, international operations management and technical expertise in the life sciences industry, as well as significant experience in strategic planning, corporate governance, and public company executive compensation matters. In addition to serving as lead director, Dr. Linton serves on the Company’s Nominating Committee.

Dr. Martin Rosenberg is the Chief Scientific Officer at Promega Corporation in Madison, WI. He joined Promega in 2001 after retiring as Senior Vice President and Director of Anti-Infectives Drug Discovery and Development at GlaxoSmithKline. He spent 20 years in the SmithKline R&D Organization and served as Senior Vice President and Director in R&D since 1993. Dr. Rosenberg serves on the Board of Directors of Promega Corporation, Madison, WI; the Medical College of Wisconsin Research Foundation, Milwaukee, WI; Cubist Pharmaceuticals, Lexington, MA; and Scarab Genomics, Madison, WI. He also served as a member of the Advisory Council for the National Institutes of Allergy & Infectious Diseases and on the Council of Councils for the Office of the Director at the National Institute of Health from 2007 through 2010. He participates on a variety of academic, industry, and venture capital Scientific Advisory Boards and holds an adjunct Professorship at the University of Wisconsin, Department of Bacteriology, Madison, WI. Dr. Rosenberg is a Senior Editor of the Journal of Bacteriology and the Journal of Microbial Biotechnology and is a member of several other journal Editorial Boards. Before joining SmithKline Pharmaceutical R&D he spent 10 years at the National Institutes of Health and was a Section Chief in the National Cancer Institute. He has served as a member of the Science Advisory Board of the FDA, and on the National Medal of Technology Evaluation Committee. He has been awarded the Arthur S. Fleming Award, the Panlabs Award in Microbiology, and the Distinguished Alumni Award from Purdue University. Dr. Rosenberg received his Ph.D. from Purdue and his postdoctoral training at Yale Medical School. He has published more than 210 papers and is the named inventor on more than 55 issued patents.

Experienced Medical Director with a demonstrated history of working in the law enforcement industry. Strong healthcare services professional skilled in Medical Devices, Oncology, Biotechnology, Managed Care, and Healthcare.

Randall Dimond is a Vice-President, Chief Technical Officer at Promega and Adjunct Professor of Bacteriology at University of Wisconsin-Madison and is based in Madison, Wisconsin. He has worked as Assoc. Professor of Bacteriology at University of Wisconsin-Madison. Randall attended UC San Diego between 1970 and 1975, University of Utah between 1964 and 1970, and Massachusetts Institute of Technology (MIT) between 1975 and 1977.

Dr. Linton serves as the lead director of our board of directors. He was appointed lead director in March 2004 by the independent members of the board of directors. As lead director, Dr. Linton performs the usual responsibilities of a lead director including acting as a liaison between management and the board of directors. Since 1978, Dr. Linton has served as the Chairman, President and Chief Executive Officer of Promega Corporation, Madison, Wisconsin, a privately held life science supply company founded by Dr. Linton. Dr. Linton received a B.S. degree from University of California, Berkeley in 1970 and an honorary Ph.D. from Hannam University (Korea) in 2004. Dr. Linton has been a director of the Wisconsin Technology Council since 2001 and also serves as a director of ALDA (Analytical, Life Science & Diagnostics Association), an industry association formerly known as Analytical & Life Sciences Systems Association, or ALSSA, and Heffter Research Institute, a non-profit medical research organization, and is President of the BioPharmaceutical Technology Center Institute. Dr. Linton brings to the board extensive executive, international operations management and technical expertise in the life sciences industry, as well as significant experience in strategic planning, corporate governance, and public company executive compensation matters. In addition to serving as lead director, Dr. Linton serves on the Company’s Nominating Committee.

Dr. Linton serves as the lead director of our board of directors. He was appointed lead director in March 2004 by the independent members of the board of directors. As lead director, Dr. Linton performs the usual responsibilities of a lead director including acting as a liaison between management and the board of directors. Since 1978, Dr. Linton has served as the Chairman, President and Chief Executive Officer of Promega Corporation, Madison, Wisconsin, a privately held life science supply company founded by Dr. Linton. Dr. Linton received a B.S. degree from University of California, Berkeley in 1970 and an honorary Ph.D. from Hannam University (Korea) in 2004. Dr. Linton has been a director of the Wisconsin Technology Council since 2001 and also serves as a director of ALDA (Analytical, Life Science & Diagnostics Association), an industry association formerly known as Analytical & Life Sciences Systems Association, or ALSSA, and Heffter Research Institute, a non-profit medical research organization, and is President of the BioPharmaceutical Technology Center Institute. Dr. Linton brings to the board extensive executive, international operations management and technical expertise in the life sciences industry, as well as significant experience in strategic planning, corporate governance, and public company executive compensation matters. In addition to serving as lead director, Dr. Linton serves on the Company’s Nominating Committee.

Dr. Martin Rosenberg is the Chief Scientific Officer at Promega Corporation in Madison, WI. He joined Promega in 2001 after retiring as Senior Vice President and Director of Anti-Infectives Drug Discovery and Development at GlaxoSmithKline. He spent 20 years in the SmithKline R&D Organization and served as Senior Vice President and Director in R&D since 1993. Dr. Rosenberg serves on the Board of Directors of Promega Corporation, Madison, WI; the Medical College of Wisconsin Research Foundation, Milwaukee, WI; Cubist Pharmaceuticals, Lexington, MA; and Scarab Genomics, Madison, WI. He also served as a member of the Advisory Council for the National Institutes of Allergy & Infectious Diseases and on the Council of Councils for the Office of the Director at the National Institute of Health from 2007 through 2010. He participates on a variety of academic, industry, and venture capital Scientific Advisory Boards and holds an adjunct Professorship at the University of Wisconsin, Department of Bacteriology, Madison, WI. Dr. Rosenberg is a Senior Editor of the Journal of Bacteriology and the Journal of Microbial Biotechnology and is a member of several other journal Editorial Boards. Before joining SmithKline Pharmaceutical R&D he spent 10 years at the National Institutes of Health and was a Section Chief in the National Cancer Institute. He has served as a member of the Science Advisory Board of the FDA, and on the National Medal of Technology Evaluation Committee. He has been awarded the Arthur S. Fleming Award, the Panlabs Award in Microbiology, and the Distinguished Alumni Award from Purdue University. Dr. Rosenberg received his Ph.D. from Purdue and his postdoctoral training at Yale Medical School. He has published more than 210 papers and is the named inventor on more than 55 issued patents.